This month, our discussion focuses on the clinical management of plexiform neurofibromas in the era of selumetinib, a MEK inhibitor medication that was approved by the FDA in 2020 for the treatment of ...
Please provide your email address to receive an email when new articles are posted on . Small cNFs were successfully reduced with four different nonsurgical treatment modalities. Deoxycholate and ...
GOMEKLI is the first FDA-approved treatment for adult and pediatric NF1-PN, showing effective tumor reduction and manageable safety. SpringWorks Therapeutics has announced the FDA approval of GOMEKLI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback